Exosome therapy is a relatively new concept, with both challenges and significant opportunities
Exosomes are nanosized vesicles (50-200nm) released naturally by cells. They are important effectors of cell communication. A key mechanism by which cell therapies work is via release and uptake of exosomes.
Some of the properties of exosomes are:
VivaZome is leveraging the best that nature and technology has to offer:
Exosome therapy is a relatively new concept, with both challenges and significant opportunities.
Special challenges with large- scale separation and concentration technology and analytics
No registered exosome therapies
Limited but growing clinical experience with exosomes
Evolving exosome-specific guidance from regulatory agencies
Growing number of industry players
Sophisticated exosome analytic technology for product specification
AMD is the leading cause of blindness in the Western World, affecting 18 million Americans, projected to reach 288 million people world-wide by 2040.
5.3 million Americans are living with Traumatic Brain Injury at a cost of USD 76.5 billion per annum.
Treatment for Critical Limb Ischemia costs >USD 10 billion per annum in USA alone.